D Coverage index
Features Benefits: How to use: Major Ingredients Water, Glycereth-26, Methylpropanediol, Butylene Glycol, Glycerin, 1,2-Hexanediol, Niacinamide, Neopentyl Glycol Diheptanoate, Polyglyceryl-3 Methylglucose Distearate, PEG-240/HDI Copolymer Bis-Decyltetradeceth-20 Ether, Caprylic/Capric Triglyceride, Phenyl Trimethicone, Glyceryl Stearate, Cyclopentasiloxane, PEG-60 Hydrogenated Castor Oil, Cyclohexasiloxane, Ammonium Acryloyldimethyltaurate/VP Copolymer, C12-16 Alcohols, Glutathione(990 ppm), Palmitic Acid, Hydrogenated Lecithin, Ethylhexylglycerin, Adenosine, Diospyros Kaki Fruit Extract, Chloramine T, Sodium Bicarbonate, Sodium Carbonate, Propanediol, Sodium Hyaluronate Crosspolymer(50 ppm), Prunella Vulgaris Extract, Fucus Vesiculosus Extract, Hydrolyzed Glycosaminoglycans(30 ppm), Glycine, Sodium Hyaluronate (15 ppm), Serine, Glutamic Acid, Potassium Laurate, Benzyl Glycol, Aspartic Acid, Leucine, BHT, Alanine, Lysine, Arginine, Tyrosine, Phenylalanine, Threonine, Proline, Valine, Isoleucine, Hydrolyzed Hyaluronic Acid(2.5 ppm), Histidine, Methionine, Cysteine, Ectoin, Ceramide NP, Water(Carbonated Water), Panthenol, Glyceryl Glucoside, Xylitylglucoside, Anhydroxylitol, Xylitol, Hyaluronic Acid(0.05 ppm), Hydrolyzed Collagen, Polyglyceryl-10 Laurate, Polyglyceryl-10 Stearate, Raspberry Ketone, Pantolactone, Sodium Ascorbyl Phosphate, Tripeptide-1, Hexapeptide-9, Acetyl Tetrapeptide-5, Copper Tripeptide-1, Biotin, Acetyl Tetrapeptide-2, Palmitoyl Pentapeptide-4, Hexapeptide-11, Pyridoxine, Folic Acid, Acetyl Hexapeptide-8, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Tocopherol, Cyanocobalamin, Alanine/Histidine/Lysine Polypeptide Copper HCl, Tripeptide-32, Linoleic Acid, Riboflavin, Beta-Carotene, Inositol, Thiamine HCl, Disodium EDTA, Fragrance Ingredients subject to change at manufacturer's discretion
(More information) Routine administration of L-carnitine to people with end-stage renal disease undergoing hemodialysis is not recommended unless it is to treat carnitine deficiency
Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression
